Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > EV / Sales (ntm)

Adverum Biotechnlgs EV / Sales (ntm) Chart (ADVM)

Adverum Biotechnlgs annual/quarterly EV / Sales (ntm) from 2015 to 2019.
  • Adverum Biotechnlgs EV / Sales (ntm) for the quarter ending October 10, 2019 was 273.62 a 29.99% increase of 82.05 year over year
  • Adverum Biotechnlgs EV / Sales (ntm) for the last 12 months ending October 10, 2019 was 273.62 a 29.99% increase of 82.05 year over year
  • Adverum Biotechnlgs Annual EV / Sales (ntm) for 2019 was 273.62 a 7.09% increase of 19.41 from 2018
  • Adverum Biotechnlgs Annual EV / Sales (ntm) for 2019 was 254.21 a 21.43% increase of 54.47 from 2018
  • Adverum Biotechnlgs Annual EV / Sales (ntm) for 2019 was 199.74 a 4.09% increase of 8.17 from 2018
Other Valuation Metrics:
  • Adverum Biotechnlgs Market Cap for the quarter ending March 03, 2018 was $361m a 70.28% increase of 253m year over year
  • Adverum Biotechnlgs Price / Book for the quarter ending March 03, 2018 was 1.54 a 65.62% increase of 1.01 year over year
  • Adverum Biotechnlgs Enterprise Value for the quarter ending March 03, 2018 was $170m a 160.05% increase of 273m year over year
View Chart On Koyfin

Quarterly ADVM EV / Sales (ntm) Data

10/2019273.62
10/2019254.21
10/2019199.74
10/2019191.57
10/2019188.16
10/2019220.17
10/2019221.53
10/2019218.80
10/2019216.76
10/2019222.55

Annual ADVM EV / Sales (ntm) Data

2019273.62
2019254.21
2019199.74
2019191.57
2019188.16
2019220.17
2019221.53
2019218.80
2019216.76
2019222.55